Literature DB >> 8954305

Autoantibody-associated sensory neuronopathy and intestinal pseudo-obstruction without detectable neoplasia.

R S Briellmann1, M Sturzenegger, H A Gerber, T Schaffner, C W Hess.   

Abstract

A 60-year-old patient presenting with the typical features of progressive sensory neuronopathy and subsequent intestinal pseudo-obstruction was found to have antineuronal nuclear antibodies (ANNA-I or Anti-Hu). These findings were suggestive of a paraneoplastic syndrome, but neither clinically nor at autopsy could a neoplasm be detected. Neuropathological findings were identical with those known for carcinoma-associated forms with marked neuron loss of spinal sensory ganglia and myenteric plexus. Therefore, ANNA-I and intestinal pseudo-obstruction may in rare cases occur without detectable underlying cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954305     DOI: 10.1159/000117295

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  4 in total

1.  Successful Treatment with Methylnaltrexone and IVIG for Paraneoplastic Syndrome-Associated Intestinal Pseudo-Obstruction.

Authors:  Cheng Zhang; Niravkumar J Patel; W Carl Jacobs; Sonal Ullman; Tyler M Berzin; Ram Chuttani; Anthony J Lembo; Jacqueline L Wolf
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

Review 2.  Sensory Neuronopathies.

Authors:  Allison Crowell; Kelly G Gwathmey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-23       Impact factor: 5.081

3.  Paraneoplastic syndromes in ganglioneuroblastoma: contrasting symptoms of constipation and diarrhoea.

Authors:  Barbara Wildhaber; Felix Niggli; Eva Bergsträsser; Thomas Stallmach; Peter Sacher
Journal:  Eur J Pediatr       Date:  2003-05-09       Impact factor: 3.183

Review 4.  Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review.

Authors:  Simone Rossi; Elena Merli; Roberto De Giorgio; Roberto D'Angelo; Rita Rinaldi; Gaia Deleonardi; Vincenzo Mastrangelo; Anna Simona Sasdelli; Alessandro Di Federico; Maria Guarino; Vincenzo Donadio; Loris Pironi; Francesco Gelsomino
Journal:  J Neurol       Date:  2021-05-02       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.